Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
4.524
Zitationen
32
Autoren
2018
Jahr
Abstract
Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previously untreated advanced renal-cell carcinoma. (Funded by Bristol-Myers Squibb and Ono Pharmaceutical; CheckMate 214 ClinicalTrials.gov number, NCT02231749 .).
Ähnliche Arbeiten
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 · 15.274 Zit.
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
2013 · 6.560 Zit.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
2015 · 5.839 Zit.
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 · 5.731 Zit.
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 · 4.772 Zit.
Autoren
- Robert J. Motzer
- Nizar M. Tannir
- Ray McDermott
- Osvaldo Arén Frontera
- Bohuslav Melichar
- Toni K. Choueiri
- Elizabeth R. Plimack
- Philippe Barthélémy
- Camillo Porta
- Saby George
- Thomas Powles
- Frede Donskov
- Victoria Neiman
- Christian Kollmannsberger
- Pamela Salman
- Howard Gurney
- Robert D. Hawkins
- Alain Ravaud
- Marc‐Oliver Grimm
- Sergio Bracarda
- Carlos H. Barrios
- Yoshihiko Tomita
- Daniel Castellano
- Brian I. Rini
- Allen C. Chen
- Sabeen Mekan
- M. Brent McHenry
- Megan Wind‐Rotolo
- Justin Doan
- Padmanee Sharma
- Hans J. Hammers
- Bernard Escudier
Institutionen
- Memorial Sloan Kettering Cancer Center(US)
- The University of Texas MD Anderson Cancer Center(US)
- Centro de Estudios Científicos(CL)
- University Hospital Olomouc(CZ)
- Palacký University Olomouc(CZ)
- Brigham and Women's Hospital(US)
- Harvard University(US)
- Dana-Farber Brigham Cancer Center(US)
- Dana-Farber Cancer Institute(US)
- Fox Chase Cancer Center(US)
- Hôpitaux Universitaires de Strasbourg(FR)
- University Hospital Foundation(CA)
- Roswell Park Comprehensive Cancer Center(US)
- Cancer Research UK(GB)
- Queen Mary University of London(GB)
- University College London(GB)
- The Royal Free Hospital(GB)
- Aarhus University Hospital(DK)
- Rabin Medical Center(IL)
- Tel Aviv University(IL)
- BC Cancer Agency(CA)
- Fundación Arturo López Pérez(CL)
- Westmead Hospital(AU)
- Macquarie University(AU)
- Cancer Research Horizons(GB)
- Hôpital Saint-André(FR)
- Jena University Hospital(DE)
- Ospedale San Donato(IT)
- Hospital São Lucas da PUCRS(BR)
- Niigata University(JP)
- Hospital Universitario 12 De Octubre(ES)
- Cleveland Clinic(US)
- Bristol-Myers Squibb (United States)(US)
- Sidney Kimmel Comprehensive Cancer Center(US)
- Institut Gustave Roussy(FR)